These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 3408794)

  • 1. In vitro platelet adhesion and in vivo antithrombogenicity of heparinized polyetherurethaneureas.
    Ito Y; Imanishi Y; Sisido M
    Biomaterials; 1988 May; 9(3):235-40. PubMed ID: 3408794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-thrombogenicity of organic polymers by blending with alkylamine-heparin complexes.
    Kashiwagi T; Ito Y; Imanishi Y
    Biomaterials; 1993 Dec; 14(15):1145-53. PubMed ID: 8130319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and antithrombogenicity of polyetherurethaneurea containing quaternary ammonium groups in the side chains and of the polymer/heparin complex.
    Ito Y; Sisido M; Imanishi Y
    J Biomed Mater Res; 1986 Sep; 20(7):1017-33. PubMed ID: 3760001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and antithrombogenicity of anionic polyurethanes and heparin-bound polyurethanes.
    Ito Y; Sisido M; Imanishi Y
    J Biomed Mater Res; 1986 Oct; 20(8):1157-77. PubMed ID: 3782177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adsorption of plasma proteins and adhesion of platelets onto novel polyetherurethaneureas--relationship between denaturation of adsorbed proteins and platelet adhesion.
    Ito Y; Sisido M; Imanishi Y
    J Biomed Mater Res; 1990 Feb; 24(2):227-42. PubMed ID: 2329117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and antithrombogenicity of heparinized polyurethanes with intervening spacer chains of various kinds.
    Liu LS; Ito Y; Imanishi Y
    Biomaterials; 1991 May; 12(4):390-6. PubMed ID: 1888808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of antithrombogenicity of a new heparinized hydrophilic polymer: chronic in vivo studies and clinical application.
    Idezuki Y; Watanabe H; Hagiwara M; Kanasugi K; Mori Y
    Trans Am Soc Artif Intern Organs; 1975; 21():436-49. PubMed ID: 1146018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of novel polyaminoetherurethaneureas and development of antithrombogenic material by their chemical modifications.
    Shibuta R; Tanaka M; Sisido M; Imanishi Y
    J Biomed Mater Res; 1986 Sep; 20(7):971-87. PubMed ID: 3760013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interaction of heparinized biomaterials with human serum, albumin, fibrinogen, antithrombin III, and platelets.
    Nemets EA; Sevastianov VI
    Artif Organs; 1991 Oct; 15(5):381-5. PubMed ID: 1741682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombogenicity of hydrophilic polyurethane-hydrophobic polystyrene IPNs. II. In vitro and ex vivo studies.
    Shin YC; Han DK; Kim YH; Kim SC
    J Biomater Sci Polym Ed; 1994; 6(3):281-95. PubMed ID: 7986781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of bacterial adhesion and biofilm formation by a heparinized hydrophilic polymer.
    Nagaoka S; Kawakami H
    ASAIO J; 1995; 41(3):M365-8. PubMed ID: 8573826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo studies on antithrombogenicity of poly(propylene oxide) segmented nylon 610 in relation to its crystalline-amorphous microstructure.
    Yui N; Kataoka K; Sakurai Y; Aoki T; Sanui K; Ogata N
    Biomaterials; 1988 May; 9(3):225-9. PubMed ID: 3408792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scanning electron microscopic comparison between the thrombogenic properties of heparinized and non-heparinized vena cava catheters. A long-term study.
    Wenning M; Höpker WW
    Virchows Arch A Pathol Anat Histol; 1981; 391(2):207-15. PubMed ID: 7222474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro blood compatibility of functional group-grafted and heparin-immobilized polyurethanes prepared by plasma glow discharge.
    Kang IK; Kwon OH; Kim MK; Lee YM; Sung YK
    Biomaterials; 1997 Aug; 18(16):1099-107. PubMed ID: 9247347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparinized polyurethane surface through ionic bonding of heparin.
    Barbucci R; Magnani A; Albanese A; Tempesti F
    Int J Artif Organs; 1991 Aug; 14(8):499-507. PubMed ID: 1937939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparinized polyurethanes: in vitro and in vivo studies.
    Heyman PW; Cho CS; McRea JC; Olsen DB; Kim SW
    J Biomed Mater Res; 1985 Apr; 19(4):419-36. PubMed ID: 4055825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New polyurethane compositions able to bond high amounts of both albumin and heparin. Part I.
    Marconi W; Galloppa A; Martinelli A; Piozzi A
    Biomaterials; 1995 Apr; 16(6):449-56. PubMed ID: 7654871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood compatibility of SPUU-PEO-heparin graft copolymers.
    Park KD; Kim WG; Jacobs H; Okano T; Kim SW
    J Biomed Mater Res; 1992 Jun; 26(6):739-56. PubMed ID: 1527098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and physicochemical characterization of a hydrophilic polyurethane able to bind heparin.
    Marconi W; Martinelli A; Piozzi A; Zane D
    Biomaterials; 1992; 13(7):432-8. PubMed ID: 1633217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of heparin immobilization on the surface characteristics of a biological tissue fixed with a naturally occurring crosslinking agent (genipin): an in vitro study.
    Tsai CC; Chang Y; Sung HW; Hsu JC; Chen CN
    Biomaterials; 2001 Mar; 22(6):523-33. PubMed ID: 11219715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.